Cardiovascular

Vitreous from patients with proliferative diabetic retinopathy induced changes in neutrophil activation markers.

TL;DR

Vitreous from patients with proliferative diabetic retinopathy showed twofold increases in CCL2, CXCL5, and angiogenin and significantly downregulated neutrophil activation markers CD11b and CD15, suggesting the presence of immunosuppressive or exhaustion-inducing factors that may alter neutrophil function in diabetic retinopathy.

Key Findings

Patients with PDR and DME had increased neutrophil-to-lymphocyte ratio (NLR) and monocyte-to-lymphocyte ratio (MLR) values compared with controls.

  • Elevated NLR and MLR values were found in both PDR (n=15) and DME (n=8) patient groups compared to surrogate controls (n=8).
  • The difference in NLR and MLR between patient groups and controls was statistically significant (p < 0.05).
  • Controls consisted of patients with rhegmatogenous retinal detachment (n=5) and macular hole (n=3).

Vitreous humor from patients with PDR showed a twofold increase in the inflammatory cytokines CCL2, CXCL5, and angiogenin compared to controls.

  • Cytokine levels were measured using an angiogenic cytokine protein array at a vitreous protein concentration of 250 mg/ml.
  • Cytokine levels were normalized to those of surrogate controls and fold changes were calculated.
  • The twofold increase was specific to PDR vitreous; DME vitreous results for these cytokines were not described as reaching the same threshold.
  • CCL2, CXCL5, and angiogenin are identified as potential therapeutic targets for PDR based on these findings.

PDR vitreous humor significantly downregulated neutrophil activation markers CD11b and CD15 compared to control vitreous humor.

  • Peripheral blood was incubated with diluted vitreous from different conditions and neutrophil activation markers were assessed via flow cytometry.
  • CD11b and CD15 expression were both significantly reduced when neutrophils were exposed to PDR vitreous (p < 0.05).
  • CD66b expression remained unchanged following exposure to PDR vitreous (p > 0.05).
  • This downregulation of activation markers suggests the presence of immunosuppressive or exhaustion-inducing factors in PDR vitreous.

DME vitreous did not significantly change any of the analyzed neutrophil activation markers (CD15, CD11b, or CD66b).

  • In vitro neutrophil stimulation with DME vitreous (from n=8 patients) did not produce significant changes in CD11b, CD15, or CD66b expression.
  • This contrasts with PDR vitreous, which significantly downregulated CD11b and CD15.
  • The finding suggests differential effects of DME versus PDR vitreous on neutrophil function.

Systemic immune-inflammation indices including platelet-to-lymphocyte ratio, neutrophil-to-lymphocyte ratio, and monocyte-to-lymphocyte ratio are useful predictors of diabetes mellitus-related diseases and inflammatory complications.

  • These indices are described as systemic markers relevant to DR pathogenesis.
  • Cumulative evidence indicates a concentration of inflammatory mediators in the vitreous humor, making its analysis a valuable tool for investigating retinal complications.
  • Both systemic and local inflammatory molecules and immune cells, particularly neutrophils, play crucial roles in DR pathogenesis.

Have a question about this study?

Citation

Maga&#xf1;a-Guerrero F, Bonilla A, Buentello-Volante B, Maga&#xf1;a-Guerrero N, Vivanco-Rojas O, Dom&#xed;nguez-L&#xf3;pez A, et al.. (2026). Vitreous from patients with proliferative diabetic retinopathy induced changes in neutrophil activation markers.. Molecular vision. https://pubmed.ncbi.nlm.nih.gov/41867378/